Dexmedetomidine added to an opioid-based analgesic regimen for the prevention of postoperative nausea and vomiting in highly susceptible patients

European Journal of Anaesthesiology

Volumn 33, Issue 2, 2016, Pages 75-83

  Song, Young ^a   Shim, Jæ Kwang ^a   Song, Jong Wook ^a   Kim, Eui Kyung ^a   Kwak, Young Lan ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE PHOSPHATE; DEXMEDETOMIDINE; FENTANYL; IBUPROFEN; KETOROLAC; METOCLOPRAMIDE; ONDANSETRON; PARACETAMOL; PETHIDINE; RAMOSETRON; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL; SPINE FUSION; XEROSTOMIA; ADVERSE EFFECTS; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; COMBINATION DRUG THERAPY; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR VERTEBRA; MALE; MIDDLE AGED; ODDS RATIO; ORTHOPEDIC SURGERY; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PROCEDURES; RISK FACTOR; SOUTH KOREA; STATISTICAL MODEL; SURGERY; TERTIARY CARE CENTER; TIME FACTOR; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; CHI-SQUARE DISTRIBUTION; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FENTANYL; HOSPITALS, UNIVERSITY; HUMANS; LINEAR MODELS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; ODDS RATIO; ORTHOPEDIC PROCEDURES; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; POSTOPERATIVE NAUSEA AND VOMITING; REPUBLIC OF KOREA; RISK FACTORS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84957626441     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000327     Document Type: Article

References (27)

1. Cohen MM, Duncan PG, DeBoer DP, Tweed WA. The postoperative interview: assessing risk factors for nausea and vomiting. Anesth Analg 1994; 78:7-16.
2. Apfel CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91:693-700.
3. Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000; 92:958-967.
4. Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014; 118:85-113.
5. Lichtor JL. Nausea and vomiting after surgery: it is not just postoperative. Curr Opin Anesthesiol 2012; 25:673-679.
6. Elia N, Lysakowski C, Tramer MR, Phil D. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology 2005; 103:1296-1304.
7. Clarke H, Pereira S, Kennedy D, et al. Adding Gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty. Acta Anæsthesiol Scand 2009; 53:1073-1083.
8. Carstensen M, Moller AM. Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: a qualitative review of randomized trials. Br J Anæsth 2010; 104:401-406.
9. Kim SH, Shin YS, Oh YJ, et al. Risk assessment of postoperative nausea and vomiting in the intravenous patient-controlled analgesia environment: predictive values of the Apfel's simplified risk score for identification of highrisk patients. Yonsei Med J 2013; 54:1273-1281.
10. Song JW, Shim JK, Song Y, et al. Effect of ketamine as an adjunct to intravenous patient-controlled analgesia, in patients at high risk of postoperative nausea and vomiting undergoing lumbar spinal surgery. Br J Anæsth 2013; 111:630-635.
11. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007; 41:245-254.
12. Iirola T, Ihmsen H, Laitio R, et al. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anæsth 2012; 108:460-468.
13. Blaudszun G, Lysakowski C, Elia N, Tramer MR. Effect of perioperative systemic alpha 2 agonists on postoperative morphine consumption and pain intensity systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2012; 116:1312-1322.
14. Lin TF, Yeh YC, Lin FS, et al. Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. Br J Anæsth 2009; 102:117-122.
15. Malviya S, Voepel-Lewis T, Ludomirsky A, et al. Can we improve the assessment of discharge readiness? A comparative study of observational and objective measures of depth of sedation in children. Anesthesiology 2004; 100:218-224.
16. Choi YS, Shim JK, Yoon do H, et al. Effect of ramosetron on patientcontrolled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron. Spine 2008; 33:E602-E606.
17. Costantini R, Affaitati G, Fabrizio A, Giamberardino MA. Controlling pain in the postoperative setting. Int J Clin Pharmacol Ther 2011; 49:116-127.
18. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77:162-184.
19. Zhang X, Bai X.New therapeutic uses for an alpha 2 adrenergic receptor agonist-dexmedetomidine in pain management. Neurosci Lett 2014; 561:7-12.
20. Kauppila T, Kemppainen P, Tanila H, Pertovaara A. Effect of systemic medetomidine, an alpha 2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology 1991; 74:3-8.
21. Zheng Y, Cui S, Liu Y, et al. Dexmedetomidine prevents remifentanil-induced postoperativehyperalgesia anddecreases spinal tyrosinephosphorylation ofNmethyl-d-aspartate receptor 2B subunit. Brain Res Bull 2012; 87:427-431.
22. Mansikka H, Zhou L, Donovan DM, et al. The role of mu-opioid receptors in inflammatory hyperalgesia and alpha 2-adrenoceptor-mediated antihyperalgesia. Neuroscience 2002; 113:339-349.
23. Ulger F, Bozkurt A, Bilge SS, et al. The antinociceptive effects of intravenous dexmedetomidine in colorectal distension-induced visceral pain in rats: the role of opioid receptors. Anesth Analg 2009; 109:616-622.
24. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90:699-705.
25. Gerlach AT, Murphy CV. Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature. Pharmacotherapy 2009; 29:1492.
26. Klinger RY, White WD, Hale B, et al. Hemodynamic impact of dexmedetomidine administration in 15,656 noncardiac surgical cases. J Clin Anesth 2012; 24:212-220.
27. Cortinez LI, Hsu YW, Sum-Ping ST, et al. Dexmedetomidine pharmacodynamics: Part II: Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004; 101:1077-1083.